In Monday’s Wall Street session, Merck & Co Inc (NYSE:MRK) shares traded at $80.43, up 5.87% from the previous session.
MRK stock price is now -6.29% away from the 50-day moving average and -19.57% away from the 200-day moving average. The market capitalization of the company currently stands at $201.96B.
With the price target of $85, Cantor Fitzgerald recently initiated with Neutral rating for Merck & Co Inc (NYSE: MRK). On February 18, 2025, Deutsche Bank Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $128 to quote $105, while ‘TD Cowen’ rates the stock as ‘Hold’
In other news, Smart Dalton E. III, SVP Fin. – Global Controller sold 4,262 shares of the company’s stock on Apr 25 ’25. The stock was sold for $352,723 at an average price of $82.76. Upon completion of the transaction, the SVP Fin. – Global Controller now directly owns 7,778 shares in the company, valued at $0.63 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 25 ’25, Officer DALTON SMART bought 4,262 shares of the business’s stock. A total of $352,723 was incurred on buying the stock at an average price of $82.76. A total of 0.10% of the company’s stock is owned by insiders.
During the past 12 months, Merck & Co Inc has had a low of $75.82 and a high of $134.63. As of last week, the company has a debt-to-equity ratio of 0.72, a current ratio of 1.41, and a quick ratio of 1.16.
The net profit margin was 27.33% and return on equity was 39.31% for MRK. The company reported revenue of $15.53 billion for the quarter, compared to $15.78 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -1.56 percent.
